Literature DB >> 8174972

Colorectal carcinoma in patients with ulcerative colitis and recent colonoscopy.

S M Catnach1, K R Rutter, R L Bown.   

Abstract

Longstanding ulcerative colitis, particularly pancolitis, is associated with an increased risk of colorectal neoplasia. For this reason surveillance colonoscopy at regular intervals has been recommended to identify early cancers or high grade dysplasia. Three cases are described of patients with ulcerative colitis of greater than 10 years duration who presented with colorectal carcinoma within three years of colonoscopy.

Entities:  

Mesh:

Year:  1993        PMID: 8174972      PMCID: PMC1374373          DOI: 10.1136/gut.34.8.1148

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  Colon cancer in ulcerative colitis.

Authors:  D F Ransohoff
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

Review 2.  Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review.

Authors:  R H Collins; M Feldman; J S Fordtran
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

3.  Compliance, cost, and common sense limit cancer control in colitis.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

4.  Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia.

Authors:  A J Woolrich; M D DaSilva; B I Korelitz
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

  4 in total
  3 in total

1.  Colonoscopic surveillance in ulcerative colitis.

Authors:  Z Rayter; R J Leicester
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

2.  Utility of surveillance colonoscopy in ulcerative colitis.

Authors:  W H Kim; P M Choi
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 3.  Gastroenterology--II: Small and large bowel, pancreas and biliary system.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.